CellOrigin Biotech (Hangzhou) Co.
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $16M
Investors
- 5
About CellOrigin Biotech (Hangzhou) Co.
, Ltd. is a biotech company that focuses on the research and development of genetically engineered pluripotent stem cells to genetically engineered pluripotent stem cells (iPSC) derived immune cell therapies. Jin Zhang, the founder of the company, used to be a scientist at Amgen before he established the company. The company has set up R&D center and production base in Hangzhou. The team members graduated from Harvard University, Zhejiang University, Scripps Research Institute and domestic pharmaceutical companies., Ltd. has obtained core patents internationally and domestically. The company engages in the research and development of iPSC-derived innate immune cell therapies. It has established a clinical-grade iPSC cell bank. The company has established three major technology platforms: a clinical-level iPSC cell bank, a clone-engineered iPSC technology platform, and an iPSC targeted and efficient differentiation immune cell technology platform. It also has drug development pipelines such as CAR-Mac MB01 and CAR-Mac MB02.
Who invested in CellOrigin Biotech (Hangzhou) Co.
5 investors across 2 rounds
See all investors in CellOrigin Biotech (Hangzhou) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CellOrigin Biotech (Hangzhou) Co.
Who invested in CellOrigin Biotech (Hangzhou) Co.?
CellOrigin Biotech (Hangzhou) Co. has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CellOrigin Biotech (Hangzhou) Co. raised?
CellOrigin Biotech (Hangzhou) Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CellOrigin Biotech (Hangzhou) Co. last raise money?
CellOrigin Biotech (Hangzhou) Co.'s most recent round on record is a Series B, in Feb 2022.
What does CellOrigin Biotech (Hangzhou) Co. do?
CellOrigin Biotech (Hangzhou) Co. is a biotechnology company.
Where is CellOrigin Biotech (Hangzhou) Co. headquartered?
CellOrigin Biotech (Hangzhou) Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like CellOrigin Biotech (Hangzhou) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at CellOrigin Biotech (Hangzhou) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CellOrigin Biotech (Hangzhou) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.